Grants and Contributions:
Title:
Anti-fibrotic engineered mesenchymal cells and development of potency assays for mesenchymal cell therapy products
Agreement Number:
914919
Agreement Value:
$165,000.00
Agreement Date:
Oct 1, 2018 - Jun 30, 2021
Description:
Mesenchymal stromal/stem cells (MSCs) exhibit numerous beneficial properties useful for a range of indications, including inflammatory diseases and regenerative medicine. We are developing an allogeneic engineered MSC product that promotes scar-less wound healing. We are also developing a biomarker screening assay for QC/QA to screen MSC potency and variability.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Port Moody, British Columbia, CA V3H 4Z6
Reference Number:
172-2018-2019-Q3-914919
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
822810180
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 150 days. The total amended value is 1,000 dollars.
Amendment Date
Feb 17, 2021
Recipient's Legal Name:
Aurora Biosolutions Inc
Federal Riding Name:
Port Moody--Coquitlam
Federal Riding Number:
59023
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541
Amendments: